The AIM-HIGH study showed that adding high doses of extended-release niacin didn’t lower risk of cardiovascular events in patients with chronic heart disease whose LDL cholesterol was already controlled with statins.
Your email address will not be published. Required fields are marked *
evolve theme by Theme4Press • Powered by WordPress
Bad Behavior has blocked 43 access attempts in the last 7 days.